A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...